De Cicco Luigi, Vavassori Andrea, Cattani Federica, Jereczek-Fossa Barbara A, Orecchia Roberto
Division of Radiotherapy, European Institute of Oncology, Milan, Italy.
Tumori. 2009 Jul-Aug;95(4):553-6. doi: 10.1177/030089160909500429.
No standard treatment exists for locally relapsed prostate cancer after primary external beam radiotherapy with no evidence of distant metastases. Radical prostatectomy, brachytherapy, cryotherapy and high-intensity focused ultrasound are currently used as local salvage treatments. Data on the safety and effectiveness of high dose rate (HDR) brachytherapy in this scenario are limited. We report on a patient who has no evidence of disease and no late urinary or gastrointestinal toxicity 33 months after receiving HDR treatment for recurrent prostate cancer.
